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The work of Panet et al.1 is a welcome addition to earlier reports on nanoparticle uptake in 
proliferating cells2,3, and provides us the opportunity to further reinforce and clarify the main 
points of our paper2 on the coupling of cell cycle progression and nanoparticle accumulation.  
Firstly we are struck by the fact that many of the experimental results and trends Panet et al. 
report are consistent with our observations, despite the very considerable differences 
between systems and experimental approaches. It is indeed pleasing that, for instance, 
average uptake rates for different cell cycle phases – if properly evaluated in the linear 
regime – are very similar (Fig. 1a-b). Obviously these refer to average uptake rates, while 
there is a distribution around them on a cell-by-cell basis (potentially including due to cell 
size) as explained in our original paper. Given the great differences in cell type and 
approach used, the level of agreement is testament to the possibility to make useful 
measurements in this field. 
We appreciate the technical approach the authors have taken in their paper, and while this is 
not the appropriate format for a detailed discussion of many technical details, we note a few 
arenas of interest. Possibly careful consideration might need to be given to particle effects 
on cellular side-scattering. This is particularly true for the highly convoluted (sub-micron 
scale) surface of cells, and to us the hypothesized relationship of this measurement to 
(appropriate) ‘cell surface areas’ is not obvious. Thus, since nanoparticles interact with the 
cell surface on that mesoscopic scale, the degree to which a fixed angle scattered light 
detector on a flow cytometer would capture these effects and accurately report an 
appropriately meaningful cell area and volume seems a question of some subtlety. 
Nowadays we are also aware that such cellular access is receptor driven, and another key 
issue that might be considered is whether the densities of receptors (via which particles 
enter) are fixed for all individual cells in all states and the degree to which this is required to 
establish useful measures of ‘area’ to nanoparticle access to receptors. 
Indeed, the capacity of conventional live cell light microscopy to resolve where nanoparticles 
are, whether on the cell surface (where they spend much of their time), cell culture plate, or 
within the cell (especially given the convoluted cell surface) has always been doubted. We 
note very carefully that nanoparticles may be associated to the surface in complex manners, 
or be involved in other (transient) complex associations that are difficult to resolve, all of 
them for much longer times than usual for molecules. The difficulty of separating surface-
associated particles (and whether external in the membrane folds or within the cell, and if so 
how far inside) will be recognized as a long-discussed challenge to bionanoscience 
investigations, in which the details and approach to ‘washing’ and many other details will be 
crucial. Many systematic electron microscopy studies of the convoluted nature of the 
nanoparticle-cell interface are sufficient warning against simple interpretations. Possibly, in 
that context also, one should be cautious to rely only on optical microscopy until all of these 
questions are seen to be resolved. One should most certainly not see these remarks as 
necessarily critical of the work of Panet et al. On the contrary, typical bionanoscience and 
many cellular studies are undertaken using quite different (and much more laborious) tools 
than those used by the authors, and the convenience of their approach will be welcomed. 
Still, since none of these issues is addressed by the authors, a more detailed understanding 
of the assumptions (and any limitations) inherent in these more convenient approaches 
would be a most welcome addition to the field. 
There are other more practical issues also. We observe that the results of Panet et al. 
describing the number of nanoparticles per cell as a function of cell size (Fig. 1c-f, h and k; 
Fig. S5-6, S8-9, S13) have significant intercepts. Given that Panet et al. concludes that the 
nanoparticle concentration is constant, we would have presumed they would pass through 
the origin (assuming that auto-fluorescence vanishes with vanishing cell volume). We are 
thus unsure of what they actually base their main conclusion on. 
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Despite points of agreement, it also must be said that we expect some different outcomes 
than those suggested by Panet et al. For example, in line with our original paper we expect 
the effects of variation of cell surface area on uptake during the cell cycle to exert only a 
minor role for the effects we report. To illustrate this simply, consider two cells at either 
extreme of the cell cycle, a cell that has just been born and a cell that is just about to divide. 
Their volumes typically differ on average by a factor of roughly 2. If the uptake rate into cells 
is proportional to cell area, as suggested by Panet et al. (their Fig. 1i), then this implies only 
a factor of 22/3 ≈ 1.6 of difference in uptake rates (Fig. 1c) – even at the extremes. A more 
complete analysis must take into account the simultaneous evolution of the cell population 
during nanoparticle exposure, as done in our previously published model.2 Extending this 
model to include cell surface area changes (see Supplementary Information) allows us to 
compare uptake kinetics obtained by including or neglecting a surface area dependence of 
the nanoparticle uptake rate (Fig. 1d). Consistent with our original report, the results clearly 
show that differences in accumulation curves due to surface area changes are barely 
measurable within the errors of the methods used. This illustrates the point that, even when 
nanoparticle entry is made dependent on cell surface area (captured for example in a short 
term accumulation experiment), the time evolution in which different cells divide, and then 
continue to progress through their cell cycle while taking up particles, leads the results we 
report to be dominated by cell cycle progression, not by the cell area dependent rates. We 
stress that, of course, area changes do occur during the cell cycle, and by necessity they will 
introduce a correlation between nanoparticle load and cell ‘volume’, a significant point to 
which we return below. However, that correlation is there whether uptake rates are made 
dependent on cell surface area or not (Supplementary Fig. S4). 
Panet et al. correctly highlight some semantic issues that deserve consideration. For 
instance, we used the phrase ‘nanoparticle intracellular concentration’ to mean number of 
nanoparticles per cell. Overall cell volume is, we feel, not the appropriate volume to discuss 
in the context of ’concentration’ (since the nanoparticles are confined in small organelles 
where the effective concentration is very large). More importantly, in distinction to the case of 
small molecules, cellular ‘concentration’ does not couple to driving force (such as the 
chemical potential) in the cell energy-dependent distribution of nanoparticles. Cellular 
concentration thus defined is therefore of uncertain value as a concept. We are also unsure 
of the real meaning of the term ‘cell size’ used by Panet et al. unless it is connected to 
surface areas and volumes, an issue that has been discussed above. Equally, our original 
terminology is now quite outdated; nowadays knowledge has moved on and, as indicated 
above, we tend to think about microscopic processes, receptor densities, and other 
molecularly based parameters, rather than such macroscopic concepts, and we feel one 
may expect these semantic issues to evolve away naturally. 
Returning to the underlying science, we stress that the central point of our original paper was 
to emphasize that nanoparticle accumulation is fundamentally coupled to cell cycle 
progression, beyond minor effects due to changing cell surface area. On this issue we 
appear to arrive at different conclusions compared to Panet et al. The reasons are not 
entirely clear. Presuming there is universal agreement on the key experimental results, 
irreversible accumulation of nanoparticles (the limited export of these particles; their 
Supplementary Fig. S15) and the sharing of those accumulated nanoparticles between 
daughter cells upon division (their Supplementary Fig. S14) then we argue that a coupling 
between cell cycle progression and nanoparticle accumulation is simply inevitable and leads 
to the results we reported in our original paper. 
It is perhaps easier to understand this difference not under conditions of continuous 
exposure (Fig. 1d), where simultaneous uptake and cell cycle progression complicate 
interpretation, but rather after a pulsed exposure (Fig. 1e).2,5 Thus, consider two cell 
populations, one exposed to nanoparticles that enter (irreversibly) by energy-dependent 
processes, and one exposed to conventional molecules that partition into and out of cells by 
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simple diffusion. After exposure, in both cases cells will contain, respectively, nanoparticles 
and molecules. However, upon removing the extracellular source, the difference between 
nanoparticles and molecules is profound. The molecules flow out rapidly (Fig. 1e; circles)5 
under diffusive control to re-adjust the concentration gradient, and the cell cycle plays no 
real role (except as a minor modulator of fluxes via cell area). On the contrary, the reduction 
of nanoparticle amounts in cells occurs solely by cell division (Fig. 1e; squares)2 and is 
directly coupled – indeed slaved – to the time-scale of the cell cycle. 
We note carefully the risk of conceptual confusion in these discussions. Thus, any parameter 
of cell structure or ultrastructure that contributes to nanoparticle accumulation, and which is 
also slaved to cell cycle (including, as noted above, cell volume) could appear to generate a 
correlation between that parameter and nanoparticle accumulation (cf. Supplementary Fig. 
S4). This is an elementary point, but worth reflecting on carefully. As a simple illustration, a 
dividing cell will split its contents – the (irreversibly) accumulated nanoparticle load and 
volume – between daughter cells, leading to a strong correlation between volume and 
nanoparticle content. It would be usual, though, to consider this correlation as being derived 
fundamentally from the progression of the cell cycle, rather than between volume and 
nanoparticle load. Additionally, there may (though we have no reason to suppose there is 
here) even be true intrinsic contributions from volume (distinct from and independent of the 
cell cycle). That is, quite simply cells with different volumes possessing different properties 
(for example variable import machinery, receptor densities etc.) accumulate particles 
differently (apart from the surface area effect). We note carefully that for this particular 
example, cell cycle progression driven volume correlations will combine with such variations 
in cell volumes, acting in the same direction (that is, giving the same ranking of 
accumulation).  It will be very challenging to separate the contributions, and attributing them 
to volume dependent rates, as the authors seek to do. Our paper was quite clear on this 
point. While we do not exclude such contributions, we found (and find) no reason to invoke 
them, as the (certain) behavior of cell cycle progression is entirely sufficient to fully explain 
the observations. Should further satisfactory evidence emerge to suggest these ‘co-
operating effects’ there could surely be no objection to such a report. However, one should 
be aware that there are many dozens of other such effects, ranging from receptor numbers 
and status to detailed microstructure of the cellular interface, that will also contribute.  
We should also note carefully that apparent correlations between volume and accumulated 
particles may (as we consider in this case) have no deeper scientific significance. The 
inverse logic, that reversible partitioning and volume-compositional correlations are tied 
together is reasonable, whereas irreversible partitioning and cell cycle driven accumulation is 
entirely consistent to any volume correlation (including a linear one). Discussions in this 
direction of causation risk returning to the arena of semantics with multiple confusions if 
incorrectly posed. That is why it so important to return once more to the core science, and 
explore the question on the basis also of pulsed exposure experiments (such as Fig. 1e; 
squares)5 rather than (near) steady-state correlations of cell parameters. The result is 
conclusive, in our view: nanoparticle accumulation is under control of the cell cycle. 
While the issues raised by Panet et al. have been addressed in the intervening years from 
our original publication, some new questions, not discussed by either of our publications, 
have arisen and we have been studying them for several years. For instance, it is long 
known that smaller subpopulations of internalized nanoparticles adopt non-endo-lysosomal 
pathways6, some transiting on cell export and recycling pathways. Such transient 
subpopulations would be lost to the cells on removal of the particle source, and their 
measurement will depend on washing and preparation steps and many other technical 
details of the experiment. Their role is a topic of some interest. Nevertheless, the 
experiments in our original paper were intended to abstract and highlight the key conclusion 
that particle accumulation is coupled to the cell cycle. They were set up (using specifically 
selected approaches) to eliminate such potentially ill-defined and transient nanoparticle 
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subpopulations and demonstrate that the major well-defined population of internalized 
nanoparticles, once accurately identified, is irreversibly accumulated in lysosomes, and 
dilution in cells is slaved to cell cycle. 
In summary, while many results in the two papers are in striking agreement (given the great 
differences in approach) there are still some differences to be resolved. We do appreciate 
and respect the fact that different perspectives and different communities of scientists will 
consider different issues of importance, and there are indeed countless parameters of 
interest for different scientists in this arena. However, for the reasons above, we do not 
expect explicit inclusion of cell surface area changes during cell cycle to substantively affect 
our reported results, nor any substantive scientific conclusions (of the type we considered). 
Rather, we believe those effects can be subordinated, as with many other genuine cellular 
effects, in capturing the major outcomes of cellular accumulation. This is fortunate since it is 
a highly challenging task to define and reliably measure real (and appropriate) highly folded 
surface areas through which nano-sized objects navigate. Secondly, significantly, we 
consider that the population of nanoparticles that accumulates in cells is most certainly 
coupled to the cell cycle, and is captured purposefully and accurately by the methods 
described in our original paper, and leads to the cell cycle phase ranking reported there. 
Other experimental approaches allowing the capture of more complex or transient 
nanoparticle-cell associations could lead to a variety of different potential (possibly poorly-
defined) volume correlations, depending on many detailed choices made in the 
measurement and analysis. While such investigations are to be welcomed, in our view, it is 
most important that reports on them do not suggest an outcome comparable to that seen for 
reversibly cell-associating small molecules where ‘equilibrium’ is expected, and 
consequently accumulation typically scales with volume. Such conclusions would miss the 
major scientific point that cell cycle and nanoparticle accumulation are intrinsically coupled, 
and qualitatively different from the molecular picture of cellular uptake. 
This conceptual distinction is as important for us to stress now as it was in our original paper, 
because of its significant scientific and practical implications. Thus, for molecular drugs there 
is little point in trying to target the cell cycle, since when the drug source is removed 
accumulated molecules are rapidly re-partitioned, and the drug washed into the blood-
stream. However, since intracellular nanoparticle accumulation is fundamentally coupled to 
cell cycle progression, targeting cycling cells is in principle possible and only demands 
design of nanoparticles that, for example, engage with cell cycle phase-specific surface 
markers. Upon removal of the source, those that thereby accumulate irreversibly will not 
repartition or ‘leak’ away rapidly. This fundamentally novel potential makes targeting of 
cycling cells (e.g., in tumours) viable in an inherently new way. 
We hope this has fully clarified certain key scientific issues in relation to the coupling of cell 
cycle progression and nanoparticle accumulation. We also expect further detail (reflected in 
molecular mechanisms) on the nature of the coupling of the cell cycle to nanoparticle uptake 
and accumulation to emerge in future. Let us also stress that many other aspects of this 
arena have important new science as yet unexplored or poorly understood, and are of 





Figure 1. Nanoparticle accumulation in proliferating cells. a, Uptake rates in L1210 cells 
of different phases. (Symbols) Data from Panet et al. (their Fig. 1j). (Lines) Our fits to 
determine uptake rates, giving rates in proportion 1.0:1.3:1.3 for G1, S and G2/M cells, 
respectively. We stress the difference between the amount of nanoparticles associated with 
cells (cell fluorescence) and nanoparticle uptake rate. The uptake rate must be evaluated 
from the linear part of the curve; we used the data after 40 or 60 min, in both cases getting 
the same proportions. The ranking in cell fluorescence, on the other hand, must be 
interpreted with care. Certainly, a large part of the signal at these short exposure times may 
come from nanoparticles adsorbed to the outer cell membrane, as we have shown 
previously4. This is consistent with larger (G2/M) cells exhibiting a higher fluorescence than 
smaller (G1) cells. Additionally, there may be a range of other transient phenomena, 
currently not well understood. b, Data from A549 cells and fits reproduced from our previous 
work (our Fig. 4) giving rates in proportion 1.0:0.8:1.2. Both works agree that uptake rates 
are roughly the same in all cell cycle phases (panels a-b). c, Schematic illustrating the small 
effect of cell volume changes during cell cycle on nanoparticle uptake. Two spherical cells, 
one (left) with half the volume of the other (right). A difference of a factor of 2 in volume gives 
only a factor of 1.26 in diameter and a factor of 1.6 in area. For simplicity the cells have been 
drawn spherical, but this is not central to the argument. d, Nanoparticle accumulation as a 
function of time in simulated A549 cells, assuming nanoparticle uptake rate (solid lines) 
independent of cell area and phase or (dotted lines) proportional to cell area. Results are 
shown for cells that are at any given moment in a given cell cycle phase. The simulations 
were performed using parameters for A549 cells from our previous work (see Supplementary 
Information for details). The results show that the overall uptake kinetics for cells in different 
cell cycle phases are roughly the same, regardless of whether the uptake rate changes with 
cell area or not. e, Experimental data comparing how the accumulated amount of small 
molecules and nanoparticles change as a function of time after removal of the source. While 
small molecules diffuse out of the cells within less than 1 h, the (irreversibly) accumulated 
nanoparticle load does not exit and decreases slowly over several hours solely due to cell 
division. Data for small molecules reproduced from ref. 5 (Fig. 4B; YG) and for nanoparticles 
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